Inceptua Group is a global service partner and specialty pharmaceutical company.
The service business units, Inceptua Clinical Trial Supply and Inceptua Early Access, support pharma and biotech companies with global clinical trial comparator sourcing, packaging, labelling, and distribution solutions and strategy, design and implementation of global early access programs (pre-approval, managed access, compassionate use).
Inceptua Pharma commercializes and markets orphan and specialty care products and have the expertise and capabilities to supply unlicensed medicines globally.
Inceptua partners with life science companies of all sizes, drawing on over 20 years of industry experience, and has global operations with local offices across Europe, North America, and Asia.
Additional information is available at: www.inceptua.com
Social Media Guidelines:
https://www.inceptua.com/inceptua-pharma/socialmediaguidelines/
|
|
|
51-200 employees
View all Inceptua Group employees
|
|
Pharmaceuticals
|
|
2 place de Paris, Luxembourg, LUX 2314, LU
|
|
1997
|
|
Distribution, Project Management, Biotech, Biosimilars, Pharmaceuticals, Clinical Trial, Storage, Rare Diseases, Commercialisation, Rare Disease, Specialty Care, Early Access, Commercial Products, Clinical Supply Chain, Real World Data, Depot Management, Compassionate Use, Expanded Access, Named Patient Programs, Comparator, Comparator Sourcing Solutions, Global Depot, Pre-Approval Access
|
Stefan Fraenkel is the CEO of Inceptua Group. To contact Stefan Fraenkel email at [email protected], [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.